{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:17:19Z","timestamp":1785381439362,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ygyno.2020.09.031","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T01:50:08Z","timestamp":1601517008000},"page":"140-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Imiquimod for vaginal intraepithelial neoplasia 2\u20133: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"160","author":[{"given":"Yoshihide","family":"Inayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Aratake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanayo","family":"Sasagasako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.09.031_bb0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2017.09.020","article-title":"Efficacy of 5% imiquimod for the treatment of vaginal intraepithelial neoplasia-a systematic review of the literature and a meta-analysis","volume":"218","author":"Tranoulis","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.02.026","article-title":"Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study","volume":"199","author":"Schockaert","year":"2008","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9378(77)90091-6","article-title":"An epidemiologic study of cancer of the cervix, vagina, and vulva based on the third National Cancer Survey in the United States","volume":"129","author":"Henson","year":"1977","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.01.047","article-title":"A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia","volume":"208","author":"Gunderson","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2020.09.031_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijgo.2011.10.033","article-title":"Diagnosis and treatment of vaginal intraepithelial neoplasia","volume":"117","author":"Wee","year":"2012","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0030","first-page":"29","article-title":"Vaginal intraepithelial neoplasia: a therapeutical dilemma","volume":"33","author":"Frega","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0035","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.09.031_bb0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2015.08.018","article-title":"Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review","volume":"139","author":"de Witte","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ygyno.2016.03.033","article-title":"Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN","volume":"141","author":"Hodeib","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/gyno.2001.6401","article-title":"Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia","volume":"83","author":"Dodge","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L","article-title":"Natural history of vaginal intraepithelial neoplasia","volume":"68","author":"Aho","year":"1991","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0002-9378(97)80018-X","article-title":"Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion and its management","volume":"176","author":"Sillman","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/LGT.0b013e31823da7fb","article-title":"Management of vaginal intraepithelial neoplasia","volume":"16","author":"Gurumurthy","year":"2012","journal-title":"J Low Genit Tract Dis."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00404-005-0022-1","article-title":"Vaginal intraepithelial neoplasia: clinical-therapeutic analysis of 33 cases","volume":"272","author":"Murta","year":"2005","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0075","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e20","article-title":"Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia","volume":"30","author":"Bogani","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0080","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e6","article-title":"Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: a comprehensive analysis of 576 cases","volume":"29","author":"Kim","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1523-1747.1998.00174.x","article-title":"Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463","volume":"110","author":"Imbertson","year":"1998","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0090","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ijd.13235","article-title":"Imiquimod in dermatology: an overview","volume":"55","author":"Hanna","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.intimp.2013.06.023","article-title":"Induction of pro-inflammatory cytokine production in thymocytes by the immune response modifiers Imiquimod and Gardiquimod","volume":"17","author":"Weber","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0100","article-title":"Committee on Gynecologic Practice. Committee opinion No. 675: management of vulvar intraepithelial neoplasia","volume":"128","author":"American College of Obstetricians and Gynecologists","year":"2016","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/0956462414554271","article-title":"2014 UK national guideline on the management of vulval conditions","volume":"26","author":"Edwards","year":"2015","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.ygyno.2020.09.031_bb0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00128360-200310000-00011","article-title":"Treatment of vaginal intraepithelial neoplasia (primarily low grade) with imiquimod 5% cream","volume":"7","author":"Buck","year":"2003","journal-title":"J Low Genit Tract Dis."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.ygyno.2020.09.031_bb0120","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/biostatistics\/kxn034","article-title":"Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction","volume":"10","author":"Tian","year":"2009","journal-title":"Biostatistics."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0130","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/01.AOG.0000435450.08980.de","article-title":"A clinicopathologic study of vaginal intraepithelial neoplasia","volume":"122","author":"Zeligs","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.tjog.2012.09.006","article-title":"Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical\/vaginal intraepithelial neoplasia","volume":"51","author":"Lin","year":"2012","journal-title":"Taiwan J Obstet Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tjog.2013.10.004","article-title":"Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm","volume":"52","author":"Chen","year":"2013","journal-title":"Taiwan J Obstet Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0145","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-15-2594","article-title":"Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar\/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response","volume":"22","author":"van Poelgeest","year":"2016","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200208013470521","article-title":"Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream","volume":"347","author":"Diakomanolis","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0155","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/LGT.0000000000000214","article-title":"Topical therapy with Imiquimod for vaginal intraepithelial Neoplasia: a case series","volume":"20","author":"Policiano","year":"2016","journal-title":"J Low Genit Tract Dis."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0160","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/ijgc-00009577-200509000-00029","article-title":"Can local application of imiquimod cream be an alternative mode of therapy for patients with high-grade intraepithelial lesions of the vagina?","volume":"15","author":"Haidopoulos","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.09.031_bb0165","first-page":"3031","article-title":"Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%","volume":"7","author":"Diaz-Arrastia","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0170","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ijc.30275","article-title":"Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management","volume":"139","author":"Tainio","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.09.031_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/LGT.0000000000000158","article-title":"Physicians\u2019 awareness, attitudes, and experiences regarding Imiquimod treatment of vaginal and cervical intraepithelial Neoplasia","volume":"20","author":"Koeneman","year":"2016","journal-title":"J Low Genit Tract Dis."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0180","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1034\/j.1600-0412.1999.780715.x","article-title":"Wide local excision (WLE) for vaginal intraepithelial neoplasia (VAIN)","volume":"78","author":"Cheng","year":"1999","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/LGT.0000000000000502","article-title":"Vaginal intraepithelial Neoplasia: a retrospective study of treatment and outcomes among a cohort of UK women","volume":"24","author":"Field","year":"2020","journal-title":"J Low Genit Tract Dis."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0190","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/lsm.22941","article-title":"LASER treatment for women with high-grade vaginal intraepithelial neoplasia: a propensity-matched analysis on the efficacy of ablative versus excisional procedures","volume":"50","author":"Bogani","year":"2018","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0195","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/AOG.0b013e31825bc6e8","article-title":"Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial","volume":"120","author":"Grimm","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0200","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ygyno.2007.05.019","article-title":"Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia","volume":"106","author":"Le","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0205","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies","volume":"50","author":"Geisse","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0210","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/ijc.25573","article-title":"Nonsteroidal anti-inflammatory drugs do not interfere with imiquimod treatment for usual type vulvar intraepithelial neoplasia","volume":"128","author":"Terlou","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.09.031_bb0215","article-title":"Frequency of Gardnerella vaginalis in vaginal smears of hysterectomized women","volume":"53","author":"Nai","year":"1992","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.ygyno.2020.09.031_bb0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.trsl.2016.07.004","article-title":"Does the vaginal microbiota play a role in the development of cervical cancer?","volume":"179","author":"Kyrgiou","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0225","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/cam4.2845","article-title":"A population-based study of age-related associations between vaginal pH and the development of cervical intraepithelial neoplasia","volume":"9","author":"Teng","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0230","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7150\/jca.35022","article-title":"Association between vaginal micro-environment disorder and cervical intraepithelial Neoplasia in a community based population in China","volume":"11","author":"Li","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.ygyno.2020.09.031_bb0235","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jps.23386","article-title":"Development of imiquimod-loaded mucoadhesive films for oral dysplasia","volume":"102","author":"Ramineni","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ygyno.2020.09.031_bb0240","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1067\/mjd.2001.113689","article-title":"Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial","volume":"44","author":"Marks","year":"2001","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582033941X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582033941X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:55:57Z","timestamp":1758772557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582033941X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S009082582033941X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.031","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imiquimod for vaginal intraepithelial neoplasia 2\u20133: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}